Tag: wealth creation
-
Revive (RVV.C) advances drug delivery tech for psychedelics
Revive has a partnership agreement with the Reed Research Group out of the University of Wisconsin-Madison to evaluate novel formulations of psilocybin.
-
Valeo Pharma Inc. (VPH.C) – THE undervalued biotech play
If you’re one of the discerning readers who bought Valeo Pharma’s stock since the last article I posted on July 6th, 2020: congratulations you should be making over 38% returns on your investment. Better yet, if you had bought Valeo’s stock a month ago, you would have been up close to 184%, which, y’know, is…
-
Nexus Gold (NXS.V) in up-trend as USD weakens
In 2020, the U.S gov. has borrowed another $7 trillion, the U.S. dollar has weakened further, the flight to gold is now a stampede and many gold juniors have experienced sharp gains in share price.
-
Nexus Gold (NXS.V) doubles down on McKenzie drill program
This $15 million company owns 11 projects on two continents.
-
Plus Products (PLUS.C) just parachuted right into my world
Heimark has a track record of rigorous market research prior to launching products. This research-based approach has reaped dividends in market penetration and revenue growth.
-
Nexus Gold (NXS.V) samples 10.5 g/t gold in Burkina Faso
For a company with a modest market cap ($9.5 million) Nexus has a good track record of advancing multiple projects simultaneously on two continents (North America and Africa).
-
Nouveau Monde Graphite (NOU.V): anatomy of a modern resource company
The company is planning a large-scale secondary graphite transformation facility, catering to the needs of the booming lithium-ion battery industry. The Matawinie graphite project will be the first of its kind to operate as an all-electric, low-carbon mine.